UncategorizedNew Releases from NCBI BookshelfBrentuximab vedotin for treating CD30-positive Hodgkin lymphoma.Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfArsenic trioxide for treating acute promyelocytic leukaemia.Arsenic trioxide for treating acute promyelocytic leukaemia. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfEribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen.Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfStrimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency.Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfSofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C.Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfFulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer.Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfTivozanib for treating advanced renal cell carcinoma.Tivozanib for treating advanced renal cell carcinoma. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfIntrabeam radiotherapy system for adjuvant treatment of early breast cancer.Intrabeam radiotherapy system for adjuvant treatment of early breast cancer. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfIbrutinib for treating relapsed or refractory mantle cell lymphoma.Ibrutinib for treating relapsed or refractory mantle cell lymphoma. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfBrodalumab for treating moderate to severe plaque psoriasis.Brodalumab for treating moderate to severe plaque psoriasis. Leave a Comment / Uncategorized / admin Post Content